

The Tapscott lab focuses on gene transcription in a chromatin context in normal development and disease. The lab uses the myogenic transcription factor MyoD to study how complex programs of gene expression unfold during cell differentiation. In addition, the lab studies gene expression in rhabdomysarcomas (cancers with characteristics of skeletal muscle) and human muscular dystrophies. Other areas of research in the lab include the formation of palindromes in the human cancer genome, gene and cell therapies for muscular dystrophy, and the biology of triplet repeats and their associated diseases. Additional information on these projects and associated publications can be found at Stephen Tapscott's Scientific Profile and Publications.


